Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Fukuda

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Journal of Human Genetics|March 2, 2018
A novel missense SNAP25b mutation in two affected siblings from an Israeli family showing seizures and cerebellar ataxiaHiroyuki Fukuda, Eri Imagawa, Kohei Hamanaka, et al.
European Journal of Radiology|June 18, 2013
Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinomaKenichi Takizawa, Kazushi Numata, Manabu Morimoto, et al.
Cardiology Research|June 22, 2026
Strong Adherence to Cardiac Rehabilitation Program Improves Exercise Tolerance in Outpatients With Cardiovascular DiseaseKakeru Bando, Yasunori Suematsu, Takuro Matsuda, et al.
European Journal of Radiology|September 28, 2011
Hyperecho in ultrasound images during high-intensity focused ultrasound ablation for hepatocellular carcinomasHiroyuki Fukuda, Kazushi Numata, Akito Nozaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 4, 2013
Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis CYu Shimoyama, Akito Nozaki, Manabu Morimoto, et al.
European Journal of Radiology|February 11, 2011
Usefulness of US-CT 3D dual imaging for the planning and monitoring of hepatocellular carcinoma treatment using HIFUHiroyuki Fukuda, Kazushi Numata, Akito Nozaki, et al.
Biological & Pharmaceutical Bulletin|February 2, 2012
A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in ratsYoichi Sunagawa, Hiromichi Wada, Hidetoshi Suzuki, et al.
European Journal of Radiology|November 2, 2013
Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinomaKazushi Numata, Hiroyuki Fukuda, Haruo Miwa, et al.
International Journal of Computer Assisted Radiology and Surgery|July 19, 2017
A new device for fiducial registration of image-guided navigation system for liver RFANobutaka Doba, Hiroyuki Fukuda, Kazushi Numata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapyKenta Yoshiura, Takashi Nakaoka, Toshihide Nishishita, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Journal of Human Genetics|March 2, 2018
A novel missense SNAP25b mutation in two affected siblings from an Israeli family showing seizures and cerebellar ataxiaHiroyuki Fukuda, Eri Imagawa, Kohei Hamanaka, et al.
European Journal of Radiology|June 18, 2013
Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinomaKenichi Takizawa, Kazushi Numata, Manabu Morimoto, et al.
Cardiology Research|June 22, 2026
Strong Adherence to Cardiac Rehabilitation Program Improves Exercise Tolerance in Outpatients With Cardiovascular DiseaseKakeru Bando, Yasunori Suematsu, Takuro Matsuda, et al.
European Journal of Radiology|September 28, 2011
Hyperecho in ultrasound images during high-intensity focused ultrasound ablation for hepatocellular carcinomasHiroyuki Fukuda, Kazushi Numata, Akito Nozaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 4, 2013
Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis CYu Shimoyama, Akito Nozaki, Manabu Morimoto, et al.
European Journal of Radiology|February 11, 2011
Usefulness of US-CT 3D dual imaging for the planning and monitoring of hepatocellular carcinoma treatment using HIFUHiroyuki Fukuda, Kazushi Numata, Akito Nozaki, et al.
Biological & Pharmaceutical Bulletin|February 2, 2012
A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in ratsYoichi Sunagawa, Hiromichi Wada, Hidetoshi Suzuki, et al.
European Journal of Radiology|November 2, 2013
Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinomaKazushi Numata, Hiroyuki Fukuda, Haruo Miwa, et al.
International Journal of Computer Assisted Radiology and Surgery|July 19, 2017
A new device for fiducial registration of image-guided navigation system for liver RFANobutaka Doba, Hiroyuki Fukuda, Kazushi Numata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapyKenta Yoshiura, Takashi Nakaoka, Toshihide Nishishita, et al.
Pageof 16